Cargando…

Effect of apoptosis in neural stem cells treated with sevoflurane

BACKGROUND: At present, sevoflurane inhalation anesthesia used on infants is well-known. But long-time exposure to inhalation anesthetic could cause neurologic disorder, especially nerve degeneration in infant and developing brain. The central nervous system degeneration of infants could affect the...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Jianlei, Shi, Pengcai, Mao, Wude, Zhao, Yuyi, Liu, Wenshuai, Wang, Yuelan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359390/
https://www.ncbi.nlm.nih.gov/pubmed/25774088
http://dx.doi.org/10.1186/s12871-015-0018-8
_version_ 1782361396360511488
author Qiu, Jianlei
Shi, Pengcai
Mao, Wude
Zhao, Yuyi
Liu, Wenshuai
Wang, Yuelan
author_facet Qiu, Jianlei
Shi, Pengcai
Mao, Wude
Zhao, Yuyi
Liu, Wenshuai
Wang, Yuelan
author_sort Qiu, Jianlei
collection PubMed
description BACKGROUND: At present, sevoflurane inhalation anesthesia used on infants is well-known. But long-time exposure to inhalation anesthetic could cause neurologic disorder, especially nerve degeneration in infant and developing brain. The central nervous system degeneration of infants could affect the memory and cognitive function. γ-Aminobutyric acid (GABA) is a known inhibitory neurotransmitter in central nervous system. Inhalation anesthetic sevoflurane may activate GABA(A) receptor to inhibit central nervous system, leading to apoptosis of neural degeneration, cognitive dysfunction in the critical period of brain development. METHODS: Neural stem cells were derived from Wistar embryos, cultured in vitro. Third generation of neural stem cells were randomly divided into four groups according to cultured suspension: Sevoflurane group (Group S), GABA(A) receptor antagonists, Bicuculline group (Group B), Sevoflurane + GABA(A) receptor antagonists, Bicuculline group (Group S + B), dimethyl sulphoxide (DMSO) group (Group D). Group B and Group D did not receive sevoflurane preconditioning. Group S and Group S + B were pretreated with 1 minimum alveolar concentration (MAC) sevoflurane for 0 h, 3 h, 6 h, and 12 h. Group S + B and Group B were pretreated with bicuculline (10 uM). Group D was treated with DMSO (10 uL/mL). After treatments above, all groups were cultured for 48 h. Then we measured the cells viability by Cell Counting Kit (CCK-8) assay, cytotoxicity by Lactate Dehydrogenase (LDH) assay, apoptosis ratio with Annexin V/propidium iodide (PI) staining by flow cytometry, and the expression of GABA(A)R, anti-apoptotic protein Bcl-2, pro-apoptotic protein Bax and Caspase-3 by western blotting. RESULTS: After exposing to sevoflurane for 0 h, 3 h, 6 h, and 12 h with 1MAC, we found that cell viability obviously decreased and cytotoxicity increased in time-dependent way. And Annexin V/PI staining indicated increased apoptosis ratio by flow cytometry. The protein level of GABA(A) receptor, pro-apoptotic protein Bax and apoptosis protein Caspase-3 increased; while anti-apoptotic protein Bcl-2 decreased. And bicuculline could reverse all detrimental results caused by sevoflurane. CONCLUSION: Sevoflurane can inhibit the central nervous system by activating GABA(A), resulting in apoptosis of neural stem cells, thus leading to the NSCs degeneration.
format Online
Article
Text
id pubmed-4359390
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43593902015-03-15 Effect of apoptosis in neural stem cells treated with sevoflurane Qiu, Jianlei Shi, Pengcai Mao, Wude Zhao, Yuyi Liu, Wenshuai Wang, Yuelan BMC Anesthesiol Research Article BACKGROUND: At present, sevoflurane inhalation anesthesia used on infants is well-known. But long-time exposure to inhalation anesthetic could cause neurologic disorder, especially nerve degeneration in infant and developing brain. The central nervous system degeneration of infants could affect the memory and cognitive function. γ-Aminobutyric acid (GABA) is a known inhibitory neurotransmitter in central nervous system. Inhalation anesthetic sevoflurane may activate GABA(A) receptor to inhibit central nervous system, leading to apoptosis of neural degeneration, cognitive dysfunction in the critical period of brain development. METHODS: Neural stem cells were derived from Wistar embryos, cultured in vitro. Third generation of neural stem cells were randomly divided into four groups according to cultured suspension: Sevoflurane group (Group S), GABA(A) receptor antagonists, Bicuculline group (Group B), Sevoflurane + GABA(A) receptor antagonists, Bicuculline group (Group S + B), dimethyl sulphoxide (DMSO) group (Group D). Group B and Group D did not receive sevoflurane preconditioning. Group S and Group S + B were pretreated with 1 minimum alveolar concentration (MAC) sevoflurane for 0 h, 3 h, 6 h, and 12 h. Group S + B and Group B were pretreated with bicuculline (10 uM). Group D was treated with DMSO (10 uL/mL). After treatments above, all groups were cultured for 48 h. Then we measured the cells viability by Cell Counting Kit (CCK-8) assay, cytotoxicity by Lactate Dehydrogenase (LDH) assay, apoptosis ratio with Annexin V/propidium iodide (PI) staining by flow cytometry, and the expression of GABA(A)R, anti-apoptotic protein Bcl-2, pro-apoptotic protein Bax and Caspase-3 by western blotting. RESULTS: After exposing to sevoflurane for 0 h, 3 h, 6 h, and 12 h with 1MAC, we found that cell viability obviously decreased and cytotoxicity increased in time-dependent way. And Annexin V/PI staining indicated increased apoptosis ratio by flow cytometry. The protein level of GABA(A) receptor, pro-apoptotic protein Bax and apoptosis protein Caspase-3 increased; while anti-apoptotic protein Bcl-2 decreased. And bicuculline could reverse all detrimental results caused by sevoflurane. CONCLUSION: Sevoflurane can inhibit the central nervous system by activating GABA(A), resulting in apoptosis of neural stem cells, thus leading to the NSCs degeneration. BioMed Central 2015-03-07 /pmc/articles/PMC4359390/ /pubmed/25774088 http://dx.doi.org/10.1186/s12871-015-0018-8 Text en © Qiu et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Qiu, Jianlei
Shi, Pengcai
Mao, Wude
Zhao, Yuyi
Liu, Wenshuai
Wang, Yuelan
Effect of apoptosis in neural stem cells treated with sevoflurane
title Effect of apoptosis in neural stem cells treated with sevoflurane
title_full Effect of apoptosis in neural stem cells treated with sevoflurane
title_fullStr Effect of apoptosis in neural stem cells treated with sevoflurane
title_full_unstemmed Effect of apoptosis in neural stem cells treated with sevoflurane
title_short Effect of apoptosis in neural stem cells treated with sevoflurane
title_sort effect of apoptosis in neural stem cells treated with sevoflurane
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359390/
https://www.ncbi.nlm.nih.gov/pubmed/25774088
http://dx.doi.org/10.1186/s12871-015-0018-8
work_keys_str_mv AT qiujianlei effectofapoptosisinneuralstemcellstreatedwithsevoflurane
AT shipengcai effectofapoptosisinneuralstemcellstreatedwithsevoflurane
AT maowude effectofapoptosisinneuralstemcellstreatedwithsevoflurane
AT zhaoyuyi effectofapoptosisinneuralstemcellstreatedwithsevoflurane
AT liuwenshuai effectofapoptosisinneuralstemcellstreatedwithsevoflurane
AT wangyuelan effectofapoptosisinneuralstemcellstreatedwithsevoflurane